



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Saturday,
                        09 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

85






                                    ANSWERED ON: 
                                

21.06.2019






R&D of Medicine




Pushpendra Singh Chandel














                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) whether the Government is planning to improve Research and Development (R&D) in medicine and if so, the details thereof;(b) whether India needs to increase the pace of research in regenerative medicine to come up to the global level, especially in the area of clinical trials and regulatory requirements and if so, thedetails thereof;(c) whether any long term plans has been prepared by the Government in this regard and if so, the details thereof;(d) the details of funds allocated for the purpose; and(e) the extent to which the Government has achieved the target and goals so far in this regard?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a):	The Department of Biotechnology, (DBT) through ‘Biotechnology Industry Research Assistance Council (BIRAC)’ a public-sector undertaking of the DBT, is supporting, strengthening and empowering the Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.The Department of Biotechnology has also initiated the Mission programme titled Industry-Academia Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals – “Innovate in India (i3) Empowering biotech entrepreneurs & accelerating inclusive innovation. Also, Indian Council of Medical Research (ICMR) has been promoting research activities in stem cell research and Regenerative Medicine through its adhoc research projects and fellowships. It has also initiated some of the task force activities and established centre for excellence and core facilities for stem cell research.(b):	The Department of Biotechnology has identified Stem Cells and Regenerative Medicine as one of the thrust areas to increase the pace of research in regenerative medicine and supporting a number of projects in this area for both basic and translational research. The “National Guidelines for Stem Cell Research-2017” has been jointly formulated by Department of Biotechnology and the Indian Council of Medical Research to lay down standards for stem cell research and ensure that research with human stem cells is conducted in a responsible and ethically sensitive manner in the country. (c):	The Department of Biotechnology has formulated the ‘National Biotechnology Development Strategy’ to promote and facilitate all aspects of biotechnology across the country. The Bio-Pharma Mission programme launched by the Department also aims to make India a hub for design and development of novel, affordable and effective biopharmaceutical products such as vaccines and biotherapeutics for combating public health concerns.(d):	The Medical Biotechnology programme is supported under the Research & Development scheme of the Department of Biotechnology with approximately Rs 100-125 crores annual budget with allocation of approx. Rs 130 crores for the current FY 2019-20. The National Biopharma Mission approved by the Cabinet at a total cost of US$250 million for five years with 50% funding through World Bank loan is being implemented by Biotechnology Industry Research Assistance Council (BIRAC) - a Public Sector Undertaking of DBT. (e):	Some of the significant outcomes of DBT’s support under Medical Biotechnology programme include: a) Development of Rapid diagnostic Kit for Celiac disease in humans and a  highly sensitive and specific Rapid 1-Day Diagnostic Test for Dengue; b) Development of  various innovative technologies and devices for day-to-day use by patients.
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113067215







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







